
Rhino Health
Healthcare AI with Federated Learning and Edge Computing.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
investor | €0.0 | round | |
* | $15.0m | Series A | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 97 % | - |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Rhino Health is a pioneering company in the healthcare technology sector, specializing in federated computing to facilitate the development of artificial intelligence (AI) solutions. The company serves academic medical centers, researchers, and companies developing AI-based medical devices and software applications. Operating primarily in the healthcare market, Rhino Health addresses the critical issue of data privacy and security by enabling AI developers to train their models on large, diverse datasets without compromising patient confidentiality. The business model revolves around providing a platform that allows for the aggregation of data from multiple sources, which is then used to create robust AI models. Rhino Health generates revenue through platform subscriptions and partnerships with healthcare institutions and AI developers. Headquartered in Boston with an R&D center in Tel Aviv, the company leverages its global network of medical centers, universities, and industry leaders to offer a comprehensive solution for AI research and development in healthcare.
Keywords: federated computing, AI development, healthcare data, medical imaging, genomics, proteomics, data privacy, clinical impact, AI research, healthcare technology.